CVE-2017-18228
CVE-2017-18228 is a medium-severity vulnerability in Bmc Remedy Action Request System with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Medium (CVSS 3.x base score 5.4)
- CVSS v2: 3.5
- EPSS exploit prediction: 1% (40th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-79
- Affected product: Bmc Remedy Action Request System
- Published:
- Last modified:
Description
Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
Frequently asked questions
- What is CVE-2017-18228?
- Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
- How severe is CVE-2017-18228?
- CVE-2017-18228 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
- Is CVE-2017-18228 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2017-18228?
- CVE-2017-18228 affects Bmc Remedy Action Request System. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2017-18228?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2017-18228 published?
- CVE-2017-18228 was published on 2018-03-12 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:*
More vulnerabilities in Bmc Remedy Action Request System
- CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
- CVE-2017-18223 — High (CVSS 8.1): BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain…
- CVE-2016-2349 — High (CVSS 7.5): Remedy AR System Server in BMC Remedy 8.1 SP 2, 9.0, 9.0 SP 1, and 9.1 allows attackers to reset arbitrary passwords…
- CVE-2015-9257 — Medium (CVSS 6.1): BMC Remedy Action Request (AR) System 9.0 before 9.0.00 Service Pack 2 hot fix 1 has persistent XSS.
- CVE-2007-0310 — Medium (CVSS 5.0): BMC Remedy Action Request System 5.01.02 Patch 1267 generates different error messages for failed login attempts with a…
All CVEs affecting Bmc Remedy Action Request System →
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →